Exicure gets Nasdaq extension to meet $2.5M equity
Nasdaq granted Exicure an extension until December 2, 2026 to restore required stockholders’ equity and avoid potential delisting of its common stock.
Rhea-AI Filing Summary
Exicure, Inc. (XCUR) received an extension from the Nasdaq Listing Qualifications Department on September 10, 2026 to regain compliance with Nasdaq Listing Rule 5550(b)(1), which requires at least $2.5 million in stockholders’ equity. The company had previously been notified on June 5, 2026 that it failed this standard and did not meet alternative continued listing criteria based on market value of listed securities or net income from continuing operations.
Under the extension, Exicure must complete its compliance initiatives and publicly demonstrate compliance with the stockholders’ equity requirement on or before December 2, 2026, while Nasdaq monitors its status through upcoming periodic reports. The company states it intends to continue pursuing its compliance initiatives, but the extension is not a determination that compliance has been regained, and Nasdaq may move to delist the common stock if the terms are not satisfied, subject to Exicure’s right to appeal to a Nasdaq Hearings Panel.
Positive
- Nasdaq granted an extension through December 2, 2026, giving Exicure additional time to execute its compliance initiatives and attempt to restore stockholders’ equity to the required level.
- The company states it intends to continue pursuing compliance initiatives, signaling an active effort to address the stockholders’ equity deficiency.
Negative
- Exicure remains out of compliance with Nasdaq’s $2.5 million stockholders’ equity requirement and also previously failed alternative continued listing standards.
- If Exicure does not meet the extension conditions by December 2, 2026, Nasdaq may issue a determination to delist the company’s common stock, with only an appeal right remaining.
- The company notes that there can be no assurance it will regain or maintain compliance with Nasdaq’s continued listing requirements.
Insights
Analyzing...
8-K Event Classification
2 items: 3.01, 9.01
2 items
Item 3.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Securities
The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Minimum stockholders’ equity requirement: $2.5 million
Extension deadline to regain compliance: December 2, 2026
Initial non-compliance notice date: June 5, 2026
+1 more
4 metrics
Minimum stockholders’ equity requirement
$2.5 million
Threshold under Nasdaq Listing Rule 5550(b)(1) for continued listing
Extension deadline to regain compliance
December 2, 2026
Date by which Exicure must demonstrate compliance with the equity requirement
Initial non-compliance notice date
June 5, 2026
Date Nasdaq notified Exicure it did not meet Listing Rule 5550(b)(1)
Extension grant date
September 10, 2026
Date Nasdaq granted the extension to regain compliance
Key Terms
Nasdaq Listing Rule 5550(b)(1), stockholders’ equity, continued listing requirements, Nasdaq Hearings Panel, +1 more
5 terms
Nasdaq Listing Rule 5550(b)(1) regulatory
"it did not satisfy Nasdaq Listing Rule 5550(b)(1), which requires a listed company"
stockholders’ equity financial
"requires a listed company to maintain a minimum of $2.5 million in stockholders’ equity"
Stockholders’ equity is the portion of a company’s value that belongs to its owners after subtracting what the company owes from what it owns — like the equity in a house after paying the mortgage. For investors it shows the company’s net worth and can indicate financial strength, a cushion against losses, and the amount potentially available to support dividends or reinvestment; tracking changes helps assess whether the business is building or eroding owner value.
continued listing requirements regulatory
"the Company has regained compliance with Nasdaq’s continued listing requirements"
Rules a stock exchange sets that a publicly traded company must keep meeting to stay listed and tradable on that exchange, such as minimum share price, market value, timely financial reports, and basic governance practices. Like a club’s membership rules, they matter because falling short can lead to warnings, penalties or removal from the exchange, which can cut liquidity, hurt share value and increase the risk for investors.
Nasdaq Hearings Panel regulatory
"which the Company would have the right to appeal to a Nasdaq Hearings Panel"
A Nasdaq hearings panel is a group of experts that reviews cases when a company's stock listing is at risk of being removed from the exchange. They evaluate whether the company has met certain standards and determine if it can keep trading on Nasdaq. This process matters to investors because it can affect a company's ability to raise money and maintain credibility in the market.
forward-looking statements regulatory
"This press release contains forward-looking statements, including statements regarding"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What Nasdaq issue is Exicure (XCUR) currently facing?
Exicure is currently not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires at least $2.5 million in stockholders’ equity. It also did not meet alternative listing standards based on market value of listed securities or net income from continuing operations.
What extension did Nasdaq grant to Exicure (XCUR)?
Nasdaq granted Exicure an extension through December 2, 2026 to regain compliance with the $2.5 million stockholders’ equity requirement. By that date, the company must complete its compliance initiatives and publicly demonstrate that it meets the applicable equity standard.
What happens if Exicure (XCUR) fails to regain Nasdaq compliance by December 2, 2026?
If Exicure does not satisfy the extension terms by December 2, 2026, Nasdaq may issue a written determination to delist the company’s common stock. Exicure would then have the right to appeal that determination to a Nasdaq Hearings Panel.
Is Exicure (XCUR) guaranteed to remain listed on Nasdaq after receiving the extension?
No. The extension does not constitute a determination that Exicure has regained compliance, and the company states there can be no assurance it will regain or maintain compliance with Nasdaq’s continued listing requirements.
What listing requirement is Exicure (XCUR) trying to satisfy?
Exicure is working to satisfy Nasdaq Listing Rule 5550(b)(1), which requires a company to maintain at least $2.5 million in stockholders’ equity to remain listed on the Nasdaq Capital Market.
How is Exicure (XCUR) describing its current strategic focus?
Exicure describes itself as a biotechnology company pursuing strategic initiatives intended to strengthen its financial position, maximize the value of its assets, and establish a foundation for future investment and business growth.
AI-generated analysis. How Rhea-AI works. Not financial advice.
